Simple asthma drug may prevent Post-Surgery lung collapse in diabetics

NCT ID NCT07591558

Not yet recruiting Prevention Sponsor: King Abdullah University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial will test whether giving a salbutamol inhaler during surgery can prevent atelectasis (partial lung collapse) in diabetic patients. Atelectasis is a common complication after chest, belly, or spine surgery. The study plans to enroll 80 adults aged 18-70 who are otherwise healthy aside from diabetes. Patients will receive 2-4 puffs of salbutamol during their operation, and doctors will check for lung collapse using vital signs, chest X-rays, and blood gas tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: salbutamol (Ventolin) inhaler
What this could lead to: If it works, this could point toward a simple, low-cost way to prevent a common post-surgery lung complication in diabetic patients.
What could go wrong: This is a very early, small trial (80 people) with no results yet. The effect may be small or not work at all, and the study only includes relatively healthy patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATELECTASES, POSTOPERATIVE PULMONARY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus Pulmonary Atelectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATELECTASES, POSTOPERATIVE PULMONARY DIABETE MELLITUS

Contacts and locations

Locations

King Abdullah University Hospital

Irbid, Jordan

More trials for these conditions

Other studies related to the condition(s) this trial covers.